Similar Search Results

Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022

more agressive, which triggers price competition and potentially deters entry by generic producers. To investigate the … branded and generic drug prices and branded market shares. Despite fiercer price competition, the number of generic producers …

Persistent link: https://www.econbiz.de/10013285854

Reference pricing of pharmaceuticals

Brekke, Kurt R. (contributor); … - 2006

Persistent link: https://www.econbiz.de/10003379831

Does pharmaceutical price regulation affect the adoption of generic competition? : evidence from the OECD, 1999-2008

Varol, Nebibe; Costa-Font, Joan; McGuire, Alistair - 2011

strategy in contrast to research-intensive pharmaceutical firms. -- generic competition ; regulation ; adoption ; discrete …Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static … adoption of generic competition. This paper aims to investigate how price regulations in the OECD affect the adoption of …

Persistent link: https://www.econbiz.de/10009124143

Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010

We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using … a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on …

Persistent link: https://www.econbiz.de/10008749029

Regulation and pricing of pharmaceuticals : reference pricing or price cap regulation?

Brekke, Kurt R. (contributor); … - 2007

Persistent link: https://www.econbiz.de/10003499685

Underrepresentation, quotas and quality : a dynamic argument for reform

Arve, Malin; Valasek, Justin - 2023

The trade-off between increased representation and perceived quality is central to the debate on how to address underrepresentation in high-profile professions. We address this trade-off using a dynamic model of career selection where juniors value both the identity and perceived quality of...

Persistent link: https://www.econbiz.de/10014282424

Competitive search with private information : can price signal quality?

Albrecht, James W.; Cai, Xiaoming; Gautier, Pieter; … - 2024

This paper considers competitive search equilibrium in a market for a good whose quality differs across sellers. Each seller knows the quality of the good that he or she is offering for sale, but buyers cannot observe quality directly. We thus have a “market for lemons” with competitive...

Persistent link: https://www.econbiz.de/10015052556

Regulation and internet access in Germany

Reutter, Michael - 2001

We explain the recent events in the German market for online access using a model of a regulated monopoly renting phone lines to retailers. Retailers offer either a linear or a flat tariff to consumers. Consumer heterogeneity leads to adverse selectiion. We show why market entry for flatrate...

Persistent link: https://www.econbiz.de/10011398800

Risk selection in natural disaster insurance : the case of France

Jametti, Mario (contributor); … - 2006

It is widely recognized that market failureʺ prevents efficient risk sharing in natural disaster insurance. As a consequence, many countries adopted institutional frameworks presenting public sector participation, often praised as public-private partnerships. We define risk selection as a...

Persistent link: https://www.econbiz.de/10003301201

How is the trade-off between adverse selection and discrimination risk affected by genetic testing? : theory and experiment

Bardey, David; De Donder, Philippe; Mantilla, César - 2017 - This version: April 2017

We compare two genetic testing regulations, Disclosure Duty (DD) and Consent Law (CL), in an environment where individuals choose to take a genetic test or not. DD forces agents to reveal the test results to their insurers, resulting in a discrimination risk. CL allows agents to withhold that...

Persistent link: https://www.econbiz.de/10011624208

1
2
3
4
5
6
7
8
9
10
Next
Last